Simplex Trading
FOLD

Simplex Trading’s Amicus Therapeutics FOLD Stock Holding History

Simplex Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$282K Sell
19,500
-1,800
-8% -$25.8K ﹤0.01% 3890
2025
Q4 		$303K Sell
21,300
-10,800
-34% -$106K ﹤0.01% 3800
2025
Q3 		$252K Buy
32,100
+19,700
+159% +$140K ﹤0.01% 4668
2025
Q2 		$71K Sell
12,400
-14,300
-54% -$92.3K ﹤0.01% 5568
2025
Q1 		$217K Buy
26,700
+25,100
+1,569% +$232K ﹤0.01% 4234
2024
Q4 		$15K Buy
+1,600
New +$16.6K ﹤0.01% 6889
2024
Q3 		– Sell
-31,100
Closed -$308K – 8834
2024
Q2 		$308K Sell
31,100
-27,900
-47% -$286K ﹤0.01% 4189
2024
Q1 		$695K Sell
59,000
-93,300
-61% -$1.19M ﹤0.01% 3502
2023
Q4 		$2.16M Buy
152,300
+73,900
+94% +$839K ﹤0.01% 2292
2023
Q3 		$953K Buy
78,400
+56,800
+263% +$733K ﹤0.01% 2709
2023
Q2 		$271K Buy
21,600
+11,500
+114% +$136K ﹤0.01% 3957
2023
Q1 		$112K Buy
10,100
+6,700
+197% +$82.6K ﹤0.01% 5021
2022
Q4 		$41K Sell
3,400
-9,100
-73% -$102K ﹤0.01% 6108
2022
Q3 		$130K Buy
12,500
+2,500
+25% +$27.9K ﹤0.01% 5172
2022
Q2 		$107K Sell
10,000
-2,500
-20% -$20.6K ﹤0.01% 5486
2022
Q1 		$118K Buy
12,500
+4,200
+51% +$39.4K ﹤0.01% 5916
2021
Q4 		$95K Sell
8,300
-70,200
-89% -$782K ﹤0.01% 6330
2021
Q3 		$775K Buy
78,500
+2,900
+4% +$29.7K ﹤0.01% 3453
2021
Q2 		$728K Buy
75,600
+73,173
+3,015% +$714K ﹤0.01% 3591
2021
Q1 		$2.4M Buy
2,427
+2,194
+942% +$34K ﹤0.01% 1428
2020
Q4 		$537K Sell
233
-179
-43% -$3.66K ﹤0.01% 3327
2020
Q3 		$581K Buy
412
+211
+105% +$3.08K ﹤0.01% 2815
2020
Q2 		$303K Sell
201
-174
-46% -$2.12K ﹤0.01% 3510
2020
Q1 		$346K Buy
375
+260
+226% +$2.47K ﹤0.01% 2989
2019
Q4 		$112K Buy
115
+101
+721% +$925 ﹤0.01% 4404
2019
Q3 		$11K Sell
14
-214
-94% -$2.32K ﹤0.01% 6188
2019
Q2 		$284K Buy
228
+217
+1,973% +$2.75K ﹤0.01% 3124
2019
Q1 		$14K Sell
11
-108
-91% -$1.32K ﹤0.01% 5933
2018
Q4 		$114K Sell
119
-68
-36% -$747 ﹤0.01% 3739
2018
Q3 		$226K Sell
187
-569
-75% -$7.96K ﹤0.01% 3514
2018
Q2 		$1.18M Buy
756
+288
+62% +$4.35K ﹤0.01% 1642
2018
Q1 		$9K Sell
468
-238
-34% -$3.62K ﹤0.01% 4114
2017
Q4 		$23K Sell
706
-45
-6% -$618 ﹤0.01% 3175
2017
Q3 		$59K Buy
751
+149
+25% +$1.97K ﹤0.01% 2151
2017
Q2 		$40K Buy
602
+102
+20% +$821 ﹤0.01% 2589
2017
Q1 		$77K Buy
500
+186
+59% +$1.18K ﹤0.01% 1974
2016
Q4 		$99K Sell
314
-346
-52% -$2.39K 0.01% 1543
2016
Q3 		$41K Buy
660
+508
+334% +$3.43K ﹤0.01% 2268
2016
Q2 		$22K Buy
152
+100
+192% +$699 ﹤0.01% 2811
2016
Q1 		$29K Sell
52
-190
-79% -$1.35K ﹤0.01% 2451
2015
Q4 		$57K Sell
242
-153
-39% -$1.38K ﹤0.01% 1814
2015
Q3 		$58K Buy
+395
New +$6.2K ﹤0.01% 1856
2015
Q2 		– Sell
-684
Closed -$19K – 5371
2015
Q1 		$19K Buy
684
+208
+44% +$1.83K ﹤0.01% 2369
2014
Q4 		$14K Buy
+476
New +$3.27K ﹤0.01% 2322

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Simplex Trading's FOLD Position: Q1 2026 in Review

Simplex Trading sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 18,857 shares — an estimated $270K sold.

Simplex Trading first reported a position in FOLD in Q4 2014 and held it in 32 quarters. The position peaked at $3.58M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Simplex Trading reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 18,857 Amicus Therapeutics shares in Q1 2026, an estimated $270K.
  • Simplex Trading first reported a position in Amicus Therapeutics in Q4 2014 and held it in 32 quarters.
  • Simplex Trading's Amicus Therapeutics position peaked at $3.58M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.